Cargando…

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review

The aim of this paper is to summarise our own and to review published experience regarding the long-term outcome of intravitreal treatment for macular neovascularisation (MNV) secondary to Sorsby’s fundus dystrophy (SFD). A systematic literature search using the MeSH terms [Sorsby] and [anti-vascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baston, Arthur, Gerhardt, Christin, Zandi, Souska, Garweg, Justus G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198854/ https://www.ncbi.nlm.nih.gov/pubmed/34070857 http://dx.doi.org/10.3390/jcm10112433

Ejemplares similares

Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
por: Kaya, Cagdas, et al.
Publicado: (2019)

Sorsby fundus dystrophy (SFD): A narrative review
por: Tsokolas, Georgios
Publicado: (2022)

OCT angiography in the management of choroidal neovascular membrane secondary to Sorsby fundus dystrophy
por: Mohla, Aditi, et al.
Publicado: (2016)

Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy
por: Wolk, Alyson, et al.
Publicado: (2020)

Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration
por: Spindler, Jan, et al.
Publicado: (2018)

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
por: Garweg, Justus G., et al.
Publicado: (2016)

Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby’s Fundus Dystrophy
por: Gourier, Hanae C. Y., et al.
Publicado: (2015)

Potential CRISPR Base Editing Therapeutic Options in a Sorsby Fundus Dystrophy Patient
por: Elsayed, Maram E. A. Abdalla, et al.
Publicado: (2022)

Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis
por: Garweg, Justus G., et al.
Publicado: (2021)

Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma
por: Garweg, Justus G., et al.
Publicado: (2017)

Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
por: Saucedo, Lucia, et al.
Publicado: (2021)

The retinal pigment epithelium in Sorsby Fundus Dystrophy shows increased sensitivity to oxidative stress-induced degeneration
por: Wolk, Alyson, et al.
Publicado: (2020)

Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines
por: Pfister, Isabel B., et al.
Publicado: (2020)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy
por: Saihan, Z., et al.
Publicado: (2009)

Deglycosylation Increases the Aggregation and Angiogenic Properties of Mutant Tissue Inhibitor of Metalloproteinase 3 Protein: Implications for Sorsby Fundus Dystrophy
por: Qi, Jian Hua, et al.
Publicado: (2022)

Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes
por: Saucedo, Lucia, et al.
Publicado: (2022)

Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series
por: Garweg, Justus G., et al.
Publicado: (2021)

Postoperative proliferative vitreoretinopathy development is linked to vitreal CXCL5 concentrations
por: Zandi, Souska, et al.
Publicado: (2021)

Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review
por: Stuart, Arabella, et al.
Publicado: (2015)

Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
por: Hamoudi, Hassan, et al.
Publicado: (2011)

The N‐terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond
por: Naessens, Sarah, et al.
Publicado: (2019)

Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism
por: Qi, Jian Hua, et al.
Publicado: (2019)

Intravitreal Fasudil Combined with Bevacizumab for Treatment of Refractory Diabetic Macular Edema; a Pilot Study
por: Nourinia, Ramin, et al.
Publicado: (2013)

Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment
por: Garweg, Justus G., et al.
Publicado: (2018)

Macular vortex vein with choroidal neovascularisation in pathologic myopia
por: Schouten, Ike M, et al.
Publicado: (2019)

Efficacy of anti-VEGF in the treatment of choroidal neovascular membrane secondary to pattern dystrophy simulating fundus flavimaculatus
por: Nangia, Purna, et al.
Publicado: (2019)

Clinical outcomes of treated macular neovascularisation secondary to inherited retinal diseases: a literature review
por: Makuloluwa, Aruni, et al.
Publicado: (2023)

Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes
por: Mathis, Thibaud, et al.
Publicado: (2022)

Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China: Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
por: Nie, Xin, et al.
Publicado: (2021)

Fractal analysis of polypoidal choroidal neovascularisation in age-related macular degeneration
por: Serra, Rita, et al.
Publicado: (2021)

The effect of intravitreal bevacizumab in a rare case of retinal dystrophy with secondary cystoid macular edema
por: Macovei, Mioara-Laura, et al.
Publicado: (2017)

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
por: Garweg, Justus G., et al.
Publicado: (2022)

Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis
por: Hänsli, Christof, et al.
Publicado: (2023)

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
por: Singerman, L J, et al.
Publicado: (2008)

A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy
por: Sulaiman, Rania S., et al.
Publicado: (2016)

Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
por: Bae, Young Hwan, et al.
Publicado: (2021)

Biomarkers for PVR in rhegmatogenous retinal detachment
por: Zandi, Souska, et al.
Publicado: (2019)

A systematic review and meta-analysis comparing intravitreal ranibizumab with bevacizumab for the treatment of myopic choroidal neovascularisation
por: Loutfi, M., et al.
Publicado: (2015)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
por: Garweg, Justus G
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a659p7oin0fmqf75k5ul2bupks